283 related articles for article (PubMed ID: 30169496)
1. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
Zhao C; Li H; Wang L; Sun W
Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma.
Ni PZ; He JZ; Wu ZY; Ji X; Chen LQ; Xu XE; Liao LD; Wu JY; Li EM; Xu LY
Oncol Rep; 2017 Dec; 38(6):3608-3618. PubMed ID: 29039594
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
4. Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma.
Liu Y; Sun X; Huo C; Sun C; Zhu J
Med Sci Monit; 2019 Jun; 25():4278-4284. PubMed ID: 31177263
[TBL] [Abstract][Full Text] [Related]
5. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer.
Nie W; Xu MD; Gan L; Huang H; Xiu Q; Li B
Lab Invest; 2015 Jan; 95(1):56-64. PubMed ID: 25384122
[TBL] [Abstract][Full Text] [Related]
7. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
8. High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.
Bai T; Yokobori T; Altan B; Ide M; Mochiki E; Yanai M; Kimura A; Kogure N; Yanoma T; Suzuki M; Bao P; Kaira K; Asao T; Katayama A; Handa T; Gombodorj N; Nishiyama M; Oyama T; Ogata K; Kuwano H
Br J Cancer; 2017 Apr; 116(9):1177-1185. PubMed ID: 28334732
[TBL] [Abstract][Full Text] [Related]
9.
Imura S; Yamada S; Saito YU; Iwahashi S; Arakawa Y; Ikemoto T; Morine Y; Utsunomiya T; Shimada M
Anticancer Res; 2017 Oct; 37(10):5877-5883. PubMed ID: 28982915
[TBL] [Abstract][Full Text] [Related]
10. Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma.
Li J; Hu G; Kong F; Wu K; Song K; He J; Sun W
Pathol Oncol Res; 2015 Sep; 21(4):1013-20. PubMed ID: 25791566
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
Tian ZZ; Guo XJ; Zhao YM; Fang Y
Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
[TBL] [Abstract][Full Text] [Related]
12. Expression of Leptin and Sirtuin-1 is associated with poor prognosis in patients with osteosarcoma.
Feng H; Guo P; Wang J; Xu J; Xie C; Gao F
Pathol Res Pract; 2016 Apr; 212(4):319-24. PubMed ID: 26936024
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma.
Nie WB; Zhao LM; Guo R; Wang MX; Ye FG
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6239-6244. PubMed ID: 30338784
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
Zou P; Ding J; Fu S
Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
[TBL] [Abstract][Full Text] [Related]
15. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
16. STMN1 in colon cancer: expression and prognosis in Chinese patients.
Zhang HQ; Guo X; Guo SQ; Wang Q; Chen XQ; Li XN; Guo LS
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2038-44. PubMed ID: 27249602
[TBL] [Abstract][Full Text] [Related]
17. High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma.
Sun K; Gong C; Peng H; Fang H; Zhou J; Li J; Chen S; Zheng H
Mol Med Rep; 2017 Nov; 16(5):6953-6957. PubMed ID: 28901496
[TBL] [Abstract][Full Text] [Related]
18. Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.
Obayashi S; Horiguchi J; Higuchi T; Katayama A; Handa T; Altan B; Bai T; Bao P; Bao H; Yokobori T; Nishiyama M; Oyama T; Kuwano H
Int J Oncol; 2017 Sep; 51(3):781-790. PubMed ID: 28766688
[TBL] [Abstract][Full Text] [Related]
19. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer.
Hemdan T; Lindén M; Lind SB; Namuduri AV; Sjöstedt E; de Ståhl TD; Asplund A; Malmström PU; Segersten U
Br J Cancer; 2014 Sep; 111(6):1180-7. PubMed ID: 25072257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]